SEC Form 4 · accession 0001179110-15-000779
ACCELERON PHARMA INC · XLRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Jean George
Director
Period of report
Jan 8, 2015
Accepted (ET)
Jan 9, 2015 · 5:50 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001280600
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common StockF1 | $41.20 | Jan 8, 2015 | A | 10,000 | A | — | Jan 8, 2025 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1The shares of common stock underlying this stock option award vest in equal quarterly installments over the first three years after the grant.